Our lawyers are now focusing our attention on the Medtronic Bravo CF capsule recall.
This device is used to diagnose acid reflux and gastroesophageal reflux disease (GERD). In September 2026, the FDA classified a major recall of these devices as Class I, the agency’s most serious recall category.
This should be a simple no-frills test. A doctor attaches a small capsule to the lining of the patient’s esophagus. The capsule measures acidity and transmits readings to a receiver the patient wears. The goal is to determine whether the patient has acid reflux.











